1-4 of 4
Kunju Sridhar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment of Higher Risk Myelodysplastic Syndrome Patients Unresponsive to Hypomethylating Agents with ON 01910.Na

Mahesh Seetharam, MD, Mai Tran, Alice C. Fan, MD, Liwen Xu, PhD, John P. Renschler, Dean W. Felsher, MD, PhD, Kunju Sridhar, PhD, Francois Wilhelm, MD, PhD., Peter L. Greenberg, MD
Journal: Blood
Blood (2010) 116 (21): 4010.
https://doi.org/10.1182/blood.V116.21.4010.4010
Published: 2010
Journal Articles

Relationship of differential gene expression profiles in CD34 + myelodysplastic syndrome marrow cells to disease subtype and progression

Kunju Sridhar, Douglas T. Ross, Robert Tibshirani, Atul J. Butte, Peter L. Greenberg
Journal: Blood
Blood (2009) 114 (23): 4847–4858.
https://doi.org/10.1182/blood-2009-08-236422
Published: 2009
Includes: Supplemental data
Journal Articles

Differential Gene Expression Profiles in CD34+ Myelodysplastic Syndrome Marrow Cells.

Kunju Sridhar, PhD, Patrick O. Brown, MD, PhD, Robert Tibshirani, PhD, Catriona Jamieson, MD, PhD, Irv Weissman, MD, Douglas T. Ross, MD, PhD, Peter L. Greenberg, MD
Journal: Blood
Blood (2005) 106 (11): 3424.
https://doi.org/10.1182/blood.V106.11.3424.3424
Published: 2005
Journal Articles

Phase II Trial of Darbepoetin Alfa in Myelodysplastic Syndrome (MDS): Preliminary Efficacy, Safety, and In Vitro Results.

Jason Gotlib, Sylvia Quesada, Jyoti Bhamidipati, Kamran Chaudry, Kunju Sridhar, Kathleen Dugan, Richard Stein, Germaine Tupper, Peter L. Greenberg
Journal: Blood
Blood (2004) 104 (11): 4737.
https://doi.org/10.1182/blood.V104.11.4737.4737
Published: 2004